BIOX
Bioceres Crop Solutions Corp.
Set alert
- YTD
- -84.12%
- 1 year
- -87.91%
- Open
- 0.23
- Prev close
- 0.2295
- Mkt cap
- 13.27M
- Vol
- 124.83K
- Avg vol
- 311.98K
- EPS
- -0.74
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2059
- High
- 0.23
- Forward P/E
- 9.88
- Beta
- 0.47
- Short ratio
- 3.12
- Inst. own
- 23.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 13, 2025
- 50-d avg
- 6.74
- 200-d avg
- 9.83
- 1y target
- 12.13
Key statistics
- Market cap
- 382.96M
- Enterprise value
- 654.75M
- Trailing P/E
- 316.00
- Forward P/E
- 9.88
- PEG ratio
- 0.00
- Price / sales
- 0.87
- Price / book
- 1.28
- EPS (TTM)
- 0.02
- Beta
- 0.47
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.55%
- Revenue (TTM)
- 441.23M
- Revenue growth
- -20.30%
- Free cash flow
- 0
- Total cash
- 38.20M
- Total debt
- 267.00M
- Return on equity
- 1.11%
- Shares outstanding
- 60.59M
- Short % of float
- 1.95%
- 50-day average
- 6.74
- 200-day average
- 9.83
Analyst view
Consensus: none
- Target (low)
- 9.50
- Target (mean)
- 12.13
- Target (high)
- 13.00
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 13, 2025
Expected Feb 13, 2025. Consensus EPS estimate 0.15.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 13, 2025 | Dec 1, 2024 | 0.14 | — | — | — |
| Nov 11, 2024 | Sep 1, 2024 | 0.02 | -0.09 | -0.11 | -550.00% |
| Sep 9, 2024 | Jun 1, 2024 | 0.20 | -0.03 | -0.23 | -115.00% |
| Sep 9, 2024 | Jun 1, 2024 | 0.20 | — | — | — |
| Feb 8, 2024 | Dec 1, 2023 | 0.07 | — | — | — |
| Feb 8, 2024 | Dec 1, 2023 | 0.07 | 0.00 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Canaccord Genuity | main | Buy | Buy |
| Oct 21, 2024 | Oppenheimer | main | Outperform | Outperform |
| Oct 17, 2024 | Canaccord Genuity | main | Buy | Buy |
| Sep 11, 2024 | Canaccord Genuity | main | Buy | Buy |
| Sep 11, 2024 | Roth MKM | main | Buy | Buy |
| Sep 11, 2024 | Lake Street | main | Buy | Buy |
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Country
- Argentina
News
- Head-To-Head Review: Chemours (NYSE:CC) & Bioceres Crop Solutions (NASDAQ:BIOX)
- Bioceres Crop Solutions (NASDAQ:BIOX) & Rayonier Advanced Materials (NYSE:RYAM) Financial Analysis
- Bioceres Crop Solutions (NASDAQ:BIOX) and Neo Performance Materials (OTCMKTS:NOPMF) Critical Survey
- Bioceres Crop Solutions Corp. (BIOX) Q4 2026 Earnings Call Transcript
- Bioceres Crop Solutions Q4 2026 Earnings Call: Complete Transcript
- Reported Earlier, Bioceres Crop Solutions Q4 EPS $(0.50) Misses $(0.06) Estimate, Sales $55.900M Miss $79.000M Estimate
- Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
- Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time
- Pinnacle Food Group (NASDAQ:PFAI) vs. Bioceres Crop Solutions (NASDAQ:BIOX) Head to Head Contrast
- Bioceres Crop Solutions Corp. (BIOX) Q3 2026 Earnings Call Transcript
Your note
Sign in to keep a note on BIOX — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Solel Partners LP | 7.29% | 4,579,364 | 28.94M | Sep 29, 2024 |
| Fourth Sail Capital LP | 5.05% | 3,171,102 | 20.04M | Sep 29, 2024 |
| Polar Capital Holdings PLC | 2.62% | 1,648,852 | 10.42M | Sep 29, 2024 |
| Ardsley Advisory Partners | 2.51% | 1,579,388 | 9.98M | Sep 29, 2024 |
| Ballast Asset Management, LP | 0.56% | 349,700 | 2.21M | Sep 29, 2024 |
| Long Focus Capital Management, LLC | 0.51% | 322,817 | 2.04M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Global X Fds-Global X MSCI Argentina ETF | 0.53% | 333,372 | 2.11M | Oct 30, 2024 |
| Unified Series Trust-Ballast Small/Mid Cap ETF | 0.43% | 271,138 | 1.71M | Sep 29, 2024 |
| Royce Smaller Companies Growth Fund | 0.25% | 155,000 | 979.60K | Sep 29, 2024 |
| Datum One Series Tr-Polar Capital Emerging Market Stars Fd | 0.15% | 96,703 | 611.16K | Sep 29, 2024 |
| Global Macro Capital Opportunities Portfolio | 0.08% | 50,100 | 316.63K | Jul 30, 2024 |
| Royce Micro Cap Trust | 0.08% | 50,000 | 316.00K | Sep 29, 2024 |